LIFE SCIENCES
BeechTree Partners Global Life Sciences Practice team is poised to serve life sciences companies in need of "best-in-class" talent. We are qualified and well positioned to fill board and senior leadership positions across the functional spectrum, from senior-level R&D roles, right through to commercial leadership roles, on an international basis.
To excel in the complex, converging life sciences space will require a new breed of leadership talent — innovative leaders with the realistic confidence, steadfastness of purpose and clear thinking ability to drive high levels of success in culturally diverse and regulated markets.
The BeechTree Partners Global Life Sciences Practice team brings years of related industry insight, experience and results to clients in the life sciences arena, including:
Pharmaceuticals & Biotechnology
The pharmaceutical and biotechnology sectors continue to be areas of great investor interest. Over the last decade, more than 10,000 deals took place among the sectors, valued at nearly $2 trillion. While tremendous opportunity exists to improve health with innovative products and services, the competitive landscape has never been more challenging, in areas such as:
- Discovery & development of new drugs for medical use
- Regulatory requirements for market approvals
- Governmental influence on reimbursement & pricing
- Patent expiry and new product pipelines
- Cultural considerations resulting from M&A activity
- Demand & resource allocation shifts based on geographic trends
back to the top
Medical Devices & Diagnostics
As the medical device sector continues to provide products in support of diagnosis, therapy and surgery, new opportunities and challenges continue to emerge. Competitive forces are accelerating the pace of medical innovation, pointing to fundamental change in the delivery of healthcare. At the same time, product recalls over the last several years are leading to more rigorous regulatory oversight.
The in-vitro diagnostics (IVD) market segment is seeing explosive growth with continued technological advancements, better diagnostic tools, improved treatment monitoring and increased availability of over-the-counter testing. The IVD market continues to be driven by pioneering work in fields such as molecular diagnostics and a growing awareness surrounding disease management.
The field of in vivo diagnostics is poised for unprecedented growth, as areas such as molecular imaging provide increasing promise for enhanced patient care. As that area becomes integrated with molecular diagnostics, a whole new era of patient care is upon us. Developments in integrated medical diagnostics are pointing us to the emergence of new IVD2 methods that combine IVD with current and developing imaging platforms, driven by new disease biomarkers, emerging imaging and IT patient–focused systems.
back to the top
Scientific & Laboratory
Innovative instrument systems are accelerating academic and clinical research, as well as drug discovery and development. Innovative reagents are exerting an impact on all major areas of biological discovery, including functional genomics, proteomics, stem cells, cell-therapy and cell biology. The ongoing development of advanced life sciences tools is helping generate earlier medical detection, more accurate results and more effective therapies.
back to the top
|
